The National Agency for the Control of AIDS, NACA, has announced that Nigeria will take delivery of Lenacapavir, a HIV prevention drug that has shown 100% effectiveness in preventing HIV infection in clinical trials.
The Head of Public Relations, NACA, Toyin Aderigbigbe, said to newsmen this Monday, that the agency has secured regulatory approval from the National Agency for Food and Drug Administration and Control, NAFDAC.
The drug is expected to be available in Nigeria and 119 other low- and middle-income countries at an affordable price of $40 per person annually, following voluntary licensing agreements with generic manufacturers.
NACA also listed some significant milestones achieved, including completion of landscape and readiness assessments across ten states including, Akwa Ibom, Anambra, Benue, Cross River, Ebonyi, FCT, Gombe, Kano, Kwara, and Lagos, alongside regulatory approval by NAFDAC.